or
forgot password
  • cancer clinical trials in milford, MA

  • Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Community Cancer Care at Milford Regional Medical Center
    Milford, Massachusetts 01757
    Breast Cancer
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
    Milford, Massachusetts 01757
    Metastatic Cancer, Prostate Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
    Milford, Massachusetts 01757
    Colorectal Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Milford Regional Medical Center
    Milford, Massachusetts 01757
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional
    Milford, Massachusetts 01757
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
    Milford, Massachusetts 01757
    Lung Cancer
    Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional
    Milford, Massachusetts 01757
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional
    Milford, Massachusetts 01757
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
    Milford, Massachusetts 01757
    Breast Cancer
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
    Milford, Massachusetts 01757
    Lung Cancer
    Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
    Milford Hospital
    Milford, Massachusetts 01757
    Waldenstrom's Macroglobulinemia
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
    Milford, Massachusetts 01757
    Colorectal Cancer
    Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
    Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
    Milford, Massachusetts 01757
    Colorectal Cancer
    T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
    Dana-Farber Cancer Institute at Milford Hospital
    Milford, Massachusetts 01757
    Breast Cancer
    The Plenaxis® Experience Study
    Tri-County Urology
    Milford, Massachusetts 01757
    Prostate Cancer